Brett Howell

Brett Howell is an experienced leader in quantitative systems pharmacology (QSP) and toxicology within the pharmaceutical industry, currently serving as Senior Director of QSP in CPMS oncology at GSK. Howell's prior roles include President of QSP Solutions at Simulations Plus, Inc., where in silico software and consulting solutions were provided to the pharmaceutical sector. As Chief Executive Officer of DILIsym Services, Howell achieved significant profitability and successfully managed an acquisition valued at $10M. Additional experience includes key positions at The Hamner Institutes for Health Sciences and academic roles at the University of Florida and North Carolina State University, where Howell obtained a Ph.D. in Chemical Engineering.